Etomidate

Aka: Etomidate, Amidate

advertisement

II. Precaution

  1. Procedural Sedation with Etomidate risks respiratory depression
  2. Monitoring is critical
    1. See Procedural Sedation and Analgesia

III. Mechanism

  1. Imidazole derivative
  2. Sedation agent with minimal Analgesic effect

IV. Contraindications

  1. Hypersensitivity to Etomidate
  2. Seizure Disorder
    1. Etomidate lowers the Seizure threshold and other agents are preferred
  3. Sepsis (risk of adrenal suppression)
    1. Avoid more than single use (e.g. induction for RSI appears safe)

V. Indication

  1. Procedural Sedation
    1. Indicated for ASA Physical Status Score 2 and 3
    2. Ketamine is usually preferred over Etomidate for sedation in children
    3. Historically agent of choice in adult Conscious Sedation
    4. Consider for sedation in hypotensive adult patient
      1. Otherwise Propofol is preferred adult sedative due to greater efficacy and less Myoclonus than Etomidate
      2. Miner (2007) Ann Emerg Med 49(1): 15-22 [PubMed]
    5. Fracture or dislocation reduction
    6. Significant Wound Debridement
    7. Rectal Foreign Body
  2. Rapid Sequence Intubation
    1. Most hemodynamically stable agent of induction medications
    2. Induction Agent of choice overall
    3. Specific scenarios in which it is especially preferred
      1. Trauma
      2. Congestive Heart Failure
      3. Hemorrhagic CVA with increased Blood Pressure

VI. Preparations

  1. Etomidate 2 mg/ml in 40 mg/20 ml prefilled syringe

VII. Dose: Induction prior to intubation (induction agent)

  1. Adult: 0.2 to 0.3 mg/kg (24 mg for an 80 kg adult) over 30-60 seconds IV
  2. Child: 0.2-0.3 mg/kg IV
    1. Ketamine may be preferred in children

VIII. Dose: Procedural Sedation

  1. IV: 0.15 to 0.2 mg/kg
    1. Repeat 0.05 mg/kg every 3-5 minutes as needed

IX. Pharmacokinetics

  1. Onset: Within 1 minute of IV dose
  2. Duration: 3-5 minutes (up to 15 minutes in some cases)
  3. Metabolized by liver
    1. Effect may be prolonged in liver failure

X. Safety

  1. Pregnancy Category C (but limited data in humans, but not generally recommended in pregnancy due to animal studies)
  2. No delay in Lactation

XI. Adverse Effects

  1. Nausea or Vomiting on emergence from agent (>10%)
    1. Consider pre-treatment with Anti-emetic, or have one available
    2. As always with Procedural Sedation, have suction with catheter on and ready for use
  2. Myoclonus or Muscle twitching (20-40% of cases)
    1. Typical duration 30-120 seconds
    2. Administer Etomidate slowly over 90 seconds
    3. Management
      1. Bag-valve mask
      2. Fentanyl 0.5 mcg/kg IV OR Ketamine 0.5 mg/kg IV
    4. Prevention
      1. Pre-treatment is generally not recommended
      2. Pre-treatment with Fentanyl, Midazolam or Magnesium Sulfate has been used
  3. Respiratory depression (in up to 15% of cases)
    1. More common when combined with Opioid Analgesics
    2. Responds to Supplemental Oxygen
    3. Positive Pressure Ventilation is rarely needed
  4. Adrenal suppression (impacts survival in Sepsis)
    1. Consider Ketamine as alternative in Sepsis
    2. Not Clinically Significant if used in single dose as induction agent for intubation
      1. McPhee (2013) Crit Care Med 41(3): 774-83 [PubMed]
    3. Avoid in Sepsis for any longer use than brief
      1. Cuthbertson (2009) Intensive Care Med 35(11): 1868-76 [PubMed]
      2. Jabre (2009) Lancet 374(9686): 293-300 [PubMed]

XII. References

  1. Acker, Koval and Leeper (2017) Crit Dec Emerg Med 31(4): 3-13
  2. Kay (2015) Crit Dec Emerg Med 29(8): 11-17
  3. Brown (2005) Am Fam Physician 71:85-90 [PubMed]
  4. Vinson (2002) Ann Emerg Med 39:592-8 [PubMed]

Images: Related links to external sites (from Bing)

These images are a random sampling from a Bing search on the term "Etomidate." Click on the image (or right click) to open the source website in a new browser window. Search Bing for all related images

Related Studies

Ontology: Etomidate (C0015131)

Definition (NCI) An imidazole derivative with short-acting sedative, hypnotic, and general anesthetic properties. Etomidate appears to have gamma-aminobutyric acid (GABA) like effects, mediated through GABA-A receptor. The action enhances the inhibitory effect of GABA on the central nervous system by causing chloride channel opening events which leads to membrane hyperpolarization.
Definition (MSH) Imidazole derivative anesthetic and hypnotic with little effect on blood gases, ventilation, or the cardiovascular system. It has been proposed as an induction anesthetic.
Concepts Pharmacologic Substance (T121) , Organic Chemical (T109)
MSH D005045
SnomedCT 387218008, 40429005
English Ethomidate, Etomidate, 1H-Imidazole-5-carboxylic acid, 1-(1-phenylethyl)-, ethyl ester, (R)-, 1H-Imidazole-5-Carboxylic Acid, 1-((1R)-1-phenylethyl)-, Ethyl Ester, R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate, etomidate (medication), sedatives etomidate, ETOMIDATE, Etomidate [Chemical/Ingredient], ethomidate, etomidate, Etomidate (product), Etomidate (substance)
Swedish Etomidat
Czech etomidát
Finnish Etomidaatti
Russian ETOMIDAT, ЭТОМИДАТ
Japanese エトミダート, エトミデート
Polish Etomidate
Spanish etomidato (producto), etomidato (sustancia), etomidato, Etomidato
French Étomidate
German Etomidat
Italian Etomidato
Portuguese Etomidato
Derived from the NIH UMLS (Unified Medical Language System)

Ontology: Amidate (C0718463)

Concepts Pharmacologic Substance (T121) , Organic Chemical (T109)
English Amidate
Derived from the NIH UMLS (Unified Medical Language System)

Related Topics in Pharmacology

advertisement

2020 Family Practice Notebook, LLC. Terms | Privacy (EHS) | About | Site Map | Blog

Footer Site Logo